Related Experiment Video

Updated: Mar 22, 2026

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.8K

Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?

Heather Wood

    Nature Reviews. Neurology
    |April 16, 2016
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
    12:01

    Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

    Published on: May 30, 2015

    11.4K
    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
    10:03

    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

    Published on: August 16, 2020

    11.5K

    Related Experiment Videos

    Last Updated: Mar 22, 2026

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
    08:33

    Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

    Published on: June 25, 2019

    8.8K
    Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
    12:01

    Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

    Published on: May 30, 2015

    11.4K
    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
    10:03

    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

    Published on: August 16, 2020

    11.5K

    Related Concept Videos

    Neural Regulation01:37

    Neural Regulation

    44.6K
    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
    44.6K
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    2.3K
    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
    2.3K
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    1.3K
    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    1.3K

    Articles linked to this work by shared authors, journal, and citation graph.

    The emerging role of microbiota in neuro-oncology.

    Nature reviews. Neurology·2026

    Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.

    Nature reviews. Neurology·2026

    Somatic mosaicism in the brain: linking development, ageing and neurodegeneration.

    Nature reviews. Neurology·2026

    Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.

    Nature reviews. Neurology·2026

    Role of complement and complement-targeted therapeutics in neurological diseases.

    Nature reviews. Neurology·2026

    Symptomatic treatment for Alzheimer disease: current evidence and future directions.

    Nature reviews. Neurology·2026

    SUN11602 Accelerates Early Peripheral Nerve Regeneration in an Experimental Median Nerve Transection Model.

    Journal of cellular and molecular medicine·2026

    The Role of Photobiomodulation Therapy in Enhancing Neurogenesis: Mechanisms and Applications.

    Photobiomodulation, photomedicine, and laser surgery·2026

    Exploratory SWI-based texture analysis of the substantia nigra on MRI in parkinson's disease.

    Medicine·2026

    Interferon-Stimulated Gene-Mediated Defense Against Prion Infection: Noncanonical Function of Oas1a.

    Viruses·2026

    Nose-to-Brain Therapeutics in Parkinson's Disease: Clinical Trials, Mechanisms, and Therapeutic Potential.

    Pharmaceutics·2026

    Neuropsychiatric Involvement in Hospitalized COVID-19 Is Embedded in Multi-Organ Disease: A Retrospective Five-Axis Record-Derived Phenotype Atlas with Renal-Urinary Prognostic Dominance.

    Pathogens (Basel, Switzerland)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us